Skip to main content

Day: February 18, 2020

DNA Brands Discusses Acquisition Candidates and Current Share Structure

Fort Lauderdale, FL, Feb. 18, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — DNA Brands is pleased to provide a shareholder update on the progress of the company to date and new business opportunities the company has been in advanced talks with.Currently the company has two business lines, which are as follows:1). The company owns a two-time Award-Winning energy drink line that consists of eight flavors.  Currently, DNA Energy Brands’ proprietary line of carbonated energy drinks includes Original, Cryo-berry, Citrus, Sugar Free Citrus, and Molecular Melon.  Along with its carbonated line of energy drinks, DNA Energy currently has three milk-based energy coffees that are fortified with Omega 3.  Those include Caramel Macchiato, Vanilla Latte and Mocha, (with the right partner DNA would consider a launch of a CBD drink line.)2)....

Continue reading

OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2019 Financial Results on March 4, 2020

WARSAW, Ind., Feb. 18, 2020 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that the Company is scheduled to release its fourth quarter and full year 2019 financial results on Wednesday, March 4, 2020, after the market closes.OrthoPediatrics will host a conference call on Thursday, March 5, 2020, at 8:00 a.m. ET to discuss the results. The dial-in numbers are (855) 289-4603 for domestic callers and (614) 999-9389 for international callers. The conference ID number is 7662677. A live webcast of the conference call will be available online from the investor relations page of the OrthoPediatrics’ corporate website at www.orthopediatrics.com.A replay of the webcast will remain available on OrthoPediatrics’ website,...

Continue reading

Turning Point Therapeutics to Participate in Upcoming Investor Conferences

SAN DIEGO, Feb. 18, 2020 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation therapies that target genetic drivers of cancer, today announced that President and CEO Athena Countouriotis, M.D., will participate in the 9th Annual SVB Leerink Global Healthcare Conference on Feb. 27 in New York and the Cowen 40th Annual Healthcare Conference on March 2 in Boston.Dr. Countouriotis is scheduled to participate in a question and answer session at 10:30 a.m. ET at the SVB Leerink conference, and present a company overview at 2:50 p.m. ET at the Cowen conference. Both sessions will be accessible via audio webcast through the Investors page of www.tptherapeutics.com.About Turning Point Therapeutics Inc.Turning Point Therapeutics is a clinical-stage precision oncology company...

Continue reading

STMicroelectronics Reveals Latest Innovation in Electric-Vehicle Energy Management for Cleaner and Safer Mobility

STMicroelectronics Reveals Latest Innovation in Electric-Vehicle Energy Management for Cleaner and Safer MobilityNew Battery-Management System chip delivers enhancements to extend driving range, reliability, and safety of electric vehiclesIntroduces industry-leading sensing accuracy, temperature monitoring, and innovative featuresGeneva, February 18, 2020 – STMicroelectronics (NYSE: STM), a global semiconductor leader serving customers across the spectrum of electronics applications, has revealed new battery-management technology that increases reliability, safety, driving range, and cost-effectiveness of electric vehicles (EVs).EVs are predicted to reach cost parity with conventional combustion-engine vehicles before the end of this decade and overtake in sales volume by 20381. ST, leveraging its technical capabilities to help car makers...

Continue reading

Taronis Hosts Turkish Delegation at Florida Production Facilities

Key Milestone for Ban of Acetylene in TurkeyPHOENIX, AZ, Feb. 18, 2020 (GLOBE NEWSWIRE) — Taronis Fuels, Inc., (“Taronis” or “the Company”), a global producer of renewable and socially responsible fuel products, today announced the successful completion of a multi-day series of meetings with senior government officials from the Turkish Ministry of Energy and Natural Resources and the Ministry of Trade. The purpose of these meetings was to provide an in-depth account of the production capabilities of the Venturi flow plasma arc gasification technology, and to demonstrate the superiority of MagneGas as a renewable and safer alternative to acetylene. Executives from Taronis also provided a detailed update on the status of the manufacturing of the five 300 KW Venturi plasma arc gasification units for delivery under an initial $18.75...

Continue reading

Digipath Announces Results for the Fiscal First Quarter 2020, Revenues Grow 26%

Gross Profit Also Increases 150% Year Over YearLAS VEGAS, NV, Feb. 18, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Digipath, Inc. (OTCQB: DIGP) (“DIGP” or the “Company”), a service-oriented independent analytical testing laboratory, data analytics and technology firm focused on the cannabis and hemp markets, today announced results for the three months ended December 31, 2019, which includes a 26% increase in revenue to $808,930 for the first quarter of 2020, compared to $642,115 in the first quarter of 2019, and gross profit of $403,449, which rose approximately 152% over the comparative quarter in 2019.First Fiscal Quarter 2020 Company HighlightsThe Company made continued progress on the development of our SabIR device, which is our fully-integrated NIR spectrometer that will enable instant field testing for THC, CBD and...

Continue reading

Adesto® and MikroElektronika Introduce mikroBUS- compatible FT Click to Speed Industrial IoT Development

SANTA CLARA, Calif., Feb. 18, 2020 (GLOBE NEWSWIRE) — Adesto Technologies Corporation (NASDAQ: IOTS), a leading provider of innovative application-specific semiconductors and systems for the Internet of Things (IoT), and MikroElektronika (Mikroe), an embedded systems designer, producer and retailer, announce availability of a new Click board that uses Adesto’s FT 6050 Smart Transceiver SoC. The plug-and-play FT Click provides a universally accepted interface via a mikroBUS™ socket to nearly any embedded IoT ecosystem so that engineers, developers, and makers can readily prototype thousands of different IoT applications.FT Click enables developers to evaluate the flexibility and capabilities of Adesto’s FT 6050 SoC, which is designed to modernize and simplify sensor, automation and control networks by using multi-drop twisted pair...

Continue reading

Resources Global Services Group (RGSG) announces progress surrounding RGS GLOBAL land parcel (SIEM REAP)

BRISBANE, Australia, Feb. 19, 2020 (GLOBE NEWSWIRE) — Resources Global Services Group (OTC Pink: RGSG) (the “Company”), announced a colossal momentum of substantial infrastructure development and planning by international organisations around the parcel of land acquired in Siem Reap, Cambodia, via a joint partnership with RGS Global. The international organisations and Global Brand Leaders from Europe and United States are on an “unstoppable path” to establish Siem Reap as a prominent tourist attraction, in North Western Cambodia.The land parcels that have been acquired, earmarked for the future development of hospitality and entertainment facilities targeted at the tourists and the local affluent society, is strategically located in the tourism corridor of the Master Plan. In September 2019, the Ministry of Tourism announced...

Continue reading

Kannalife Bolsters its Global Intellectual Property Portfolio with New Chinese-Issued Patent

DOYLESTOWN, Pa., Feb. 18, 2020 (GLOBE NEWSWIRE) — Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB: KLFE), a biopharmaceutical company specializing in the research and development of cannabinoid therapeutics, announced today that China has issued the Company, Chinese Patent CN106456573B (the “Patent”) specific to “Novel Functionalized 1,3-Benzene Diols and their Method of Use for the Treatment of Hepatic Encephalopathy,” which further bolsters the Company’s global patent portfolio of cannabidiol (CBD)-like molecules. The Company anticipates receipt of patent grants from the EU and Australia sometime during the first and second quarters of 2020.Kannalife’s intellectual property estate of CBD-like molecules (“KLS Family”), which is led by KLS-13019, are capable of acting as neuroprotective agents and have the potential to treat...

Continue reading

Neovasc to Participate in SVB Leerink 9th Annual Global Healthcare Conference on February 26, 2020

VANCOUVER, Feb. 18, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today announced that Fred Colen, CEO of Neovasc, will be participating in the SVB Leerink 9th Annual Global Healthcare Conference on Wednesday, February 26, 2020 in New York City.  Mr. Colen’s presentation will take place at 3:00 p.m. EST.A link to the live webcast of the presentation will be available online from the investor relations section of the Neovasc website at https://www.neovasc.com/investors/A replay of the webcast will be accessible through the Neovasc investor relations...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.